Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer Ingelheim's zongertinib as a first-line treatment for a rare form of non-small cell lung cancer, making it the ...

A first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people’s lung cells has been fast-tracked towards potential approval after promising clinical trial results. “Very ...

Posts from this topic will be added to your daily email digest and your homepage feed. The most interesting thing about Markiplier’s horror flick is its journey from YouTube to the big screen. The ...

For years, scientists have viewed cancer as a localized glitch in which cells refuse to stop dividing. But a new study suggests that, in certain organs, tumors actively communicate with the brain to ...

Hoover Institution senior fellow Victor Davis Hanson offered a rare direct update on his health Monday following lung cancer surgery. In December, Hanson, 72, a famed author, scholar and conservative ...

This first theatrical feature by a YouTube celebrity flatters his directing and acting skills, though the claustrophobic sci-fi horror tale itself wears thin. Last week’s movie conversation was all ...

Patients with advanced lung cancer had better survival outcomes when they received immunochemotherapy earlier in the day, a randomized trial showed. Morning circulating CD8+ T cells increased in the ...

I specialize in treating people who are immunocompromised from leukemia or other cancers affecting the cells of the bone marrow. Recently, I was reviewing the medications one of my patients was taking ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

The five-year cancer survival rate has reached 70%, driven by treatment advances, reduced smoking, and early detection, yet lung cancer remains the leading cause of cancer deaths. Disparities in ...

The disease is the rare cancer met with accusations, not sympathy. By Simar Bajaj Simar Bajaj spoke to over a dozen patients with lung cancer for this story. When Jim Pantelas was diagnosed with lung ...